MedTrace Logo

Use of ROTEM Intraoperatively in Women With Placenta Accreta

NCT02729974 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-04-15

No results posted yet for this study

Summary

This study evaluates the use of rapid tests for hematocrit and clotting function in women undergoing surgery for placenta accreta. Half of participants will have these rapid tests performed during surgery to guide blood product transfusion and the other half will have standard lab tests performed to guide transfusion.

Conditions

  • Placenta Accreta

Interventions

PROCEDURE

ROTEM

rapid testing of blood clot formation

PROCEDURE

standard treatment

visual assessment of blood loss and clotting function every 30 minutes, combined with standard laboratory testing when indicated

Sponsors & Collaborators

Principal Investigators

  • Heather Campbell, MD · University of Utah, Department of OBGYN

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-08
Primary Completion
2024-12-31
Completion
2025-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02729974 on ClinicalTrials.gov